Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-16-156578

Chief Medical Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bahrt Kenneth · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2016-12-21 Grant or award : show line 1 in the form +50,000 80,985 D
Loading xslF345X03/doc4.xml…